All In Biotech

Drug Trial Radar · NCT04024137

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

A Randomized, Double-blind, Placebo-controlled, Phase 2 Study of ZSP1273 in Adults With Acute Uncomplicated Influenza A

Last checked: Nov 19, 2026Latest source record: Jun 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 172 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

172

Actual

Start

Dec 7, 2019

Primary completion

May 18, 2020

Study completion May 18, 2020

Sponsor

Sponsor type
Industry
First posted
Jul 18, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the antiviral effect, as measured by the time to alleviation of influenza symptoms and viral titer in nasopharyngeal secretions in adults with acute uncomplicated influenza A following administration of ZSP1273.

Conditions

  • Influenza A

Interventions

  • ZSP1273 200 mgDrug

    1 X 200-mg tablet taken orally

  • PlaceboDrug

    2 tablets taken orally

  • ZSP1273-400 mgDrug

    2 X 200-mg tablet taken orally

  • PlaceboDrug

    1 tablet taken orally

  • ZSP1273-600 mgDrug

    3 X 200-mg tablet taken orally

  • PlaceboDrug

    3 tablets taken orally

  • PlaceboDrug

    Subjects will receive matching placebo of ZSP1273

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to alleviation of influenza symptoms in participantsTime frame: Initiation of study treatment (Day 1) up to Day 15

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • The Second Hospital Of Anhui Medical University

    Hefei, Anhui, China

  • Beijing Ditan Hospital Capital Medical University

    Beijing, Beijing Municipality, China

  • Beijing Luhe Hospital,Capital Medical University

    Beijing, Beijing Municipality, China

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China

  • Zhongshan Hospital Xiamen University

    Xiamen, Fujian, China

  • Dongguan people's Hospital

    Dongguan, Guangdong, China

  • Nanfang Hospital,South Medical Hospital

    Guangzhou, Guangdong, China

  • The First Affiliated Hospital Of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • Traditional Chinese Medicine Hospital of Guangdong Province

    Guangzhou, Guangdong, China

  • Huizhou Municipal Central Hospital

    Huizhou, Guangdong, China

  • Jieyang People's Hospital

    Jieyang, Guangdong, China

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, China

  • Affiliated Hospital Of Guangdong Medical University

    Zhanjiang, Guangdong, China

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China

  • The Sixth People's Hospital Of Zhengzhou

    Zhengzhou, Henan, China

  • Sir Run Run Hospital Nanjing Medical University

    Nanjing, Jiangsu, China

  • Jiujiang University Hospital

    Jiujiang, Jiangxi, China

  • The First Affiliated Hospital Of Nanchang University

    Nanchang, Jiangxi, China

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China

  • Linyi People's Hospital

    Linyi, Shandong, China

  • Qingdao Municipal Hospital

    Qingdao, Shandong, China

  • First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China

  • Chengdu Fifth People's Hospital

    Chengdu, Sichuan, China

  • General Hospital, Tianjin Medical University

    Tianjin, Tianjin Municipality, China

  • The First Affiliated Hospital,Zhejiang University

    Hangzhou, Zhejiang, China

  • Zhejiang Provincial People's Hospital

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.